Greenlight Capital’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

Greenlight Capital’s Portfolio NUVB.WS Stock Details NUVB.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$6K	Hold	100,000	–	–	﹤0.01%	39
2023 Q3	$10K	Hold	100,000	–	–	﹤0.01%	37
2023 Q2	$16.5K	Hold	100,000	–	–	﹤0.01%	39
2023 Q1	$12K	Hold	100,000	–	–	﹤0.01%	38
2022 Q4	$14.4K	Hold	100,000	–	–	﹤0.01%	39
2022 Q3	$20K	Hold	100,000	–	–	﹤0.01%	40
2022 Q2	$28K	Hold	100,000	–	–	﹤0.01%	45
2022 Q1	$81K	Hold	100,000	–	–	0.01%	49
2021 Q4	$189K	Hold	100,000	–	–	0.01%	49
2021 Q3	$256K	Hold	100,000	–	–	0.02%	49
2021 Q2	$260K	Hold	100,000	–	–	0.02%	61
2021 Q1	$267K	Buy	+100,000	New	+$289K	0.02%	54

Other funds holding NUVB.WS

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Greenlight Capital's NUVB.WS Position: Q4 2023 in Review

Greenlight Capital held its Nuvation Bio Inc Warrants (NUVB.WS) position steady in Q4 2023 at 100,000 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #39.

Greenlight Capital first reported a position in NUVB.WS in Q1 2021 and has held it in 12 quarters since. The position peaked at $267K in Q1 2021. 17 funds tracked by Wall St. Rank hold NUVB.WS as of Q4 2023.

Greenlight Capital held 100,000 shares of Nuvation Bio Inc Warrants worth $6K as of Q4 2023.
Greenlight Capital left its Nuvation Bio Inc Warrants share count unchanged in Q4 2023.
Nuvation Bio Inc Warrants made up ﹤0.01% of Greenlight Capital's portfolio in Q4 2023, its #39 holding.
Greenlight Capital first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and has held it in 12 quarters since.
Greenlight Capital's Nuvation Bio Inc Warrants position peaked at $267K in Q1 2021.
17 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q4 2023.

Based on Greenlight Capital's 13F filing for Q4 2023, filed 14 Feb 2024.